Results 251 to 260 of about 3,050,636 (322)

Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States

Arthritis Care &Research, EarlyView.
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley   +1 more source

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang, Sandra Blitz, Nick Bansback, Michael Law, Mark Harrison   +4 more
wiley   +1 more source

Constructing a confidence interval for the fraction who benefit from treatment, using randomized trial data. [PDF]

Biometrics, 2019
Huang EJ, Fang EX, Hanley DF, Rosenblum M.   +3 more
europepmc   +1 more source

Comparison of Risk Differences (RD) and Odds Ratios (OR) with 95% confidence intervals for different methods used to evaluate the association between obesity and diabetes risk. The analysis is based on data from the National Health and Nutrition Examination Survey (NHANES) for the years 2013–2018. Methods are arranged by the number of variables used in the models.

Mohammad Ehsanul Karim (3234213), Yang Lei (136316)   +1 more
openalex   +1 more source

Improving likelihood-ratio-based confidence intervals for threshold parameters in finite samples

, 2017
Luiggi Donayre, Yunjong Eo, James Morley
openalex   +2 more sources

Reduction in Renal Relapse and Preservation of Long‐Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond Y. H. Yap, Ka Lai Lee, Philip H. Li, Iris Y. K. Tang, Chak Sing Lau, Shirley C. W. Chan   +6 more
wiley   +1 more source

The standardized coefficients (mean ±  95% confidence interval) of Linear Mixed Models for fish ecological indicators calculated for protected (MUMPA: blue) and non-protected (NP: orange) sites of the Oaxaca coast are presented.

Georgina Ramírez-Ortiz (21484870), Omar Valencia-Méndez (5706572), Luis Hernández (4524061), Tania González-Mendoza (21484873), Andrés López-Pérez (5698760)   +4 more
openalex   +1 more source

Development of a Personalized Visualization and Analysis Tool to Improve Clinical Care in Complex Multisystem Diseases With Application to Scleroderma

Arthritis Care &Research, EarlyView.
Objective In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently, and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of the trajectory of a ...
Ji Soo Kim, John Scott, Lauren Fisher, Lauren N. Smith, Willie Stewart, Adrianne Woods, Rob Smithwright, Diane Koher, Parastoo Aslanbeik, Aalok B. Shah, Brad Tibbils, Samantha I. Pitts, Ayse P. Gurses, Yushi Yang, Ana‐Maria Orbai, Antony Rosen, Laura K. Hummers, Scott L. Zeger, Ami A. Shah   +18 more
wiley   +1 more source